JAN News and Press, JanOne Inc. From 12/30/20

Indonesia Energy Corporation (INDO) +158%.Conifer Holdings (CNFR) +112%.Bionano Genomics (BNGO) +41%.JanOne (JAN) +40%.Net Element (NETE +38% as Mullen Technologies receives LOI for purchase order of 1,500 MX-05 EV.Hepion Pharmaceuticals (HEPA +35% on announcing positive d...

Gainers: Pioneer Power Solutions (PPSI) +26%. Pitney Bowes (PBI) +14%. Quest Resource (QRHC) +12%. JanOne (JAN) +11%. Wilhelmina International (WHLM) +8%.Losers: Greenland Technologies (GTEC) -21%. Atlas Technical Consultants (ATCX) -16%. FreightCar America (RAIL) -15...

JanOne ([[JAN]] -7.2%) has started production of JAN101 for its anticipated Phase 2b trials in Peripheral Artery Disease ((PAD)) and as a potential treatment for COVID-19 vascular complications.The initial production batch will be 250k sustained release tablets and matching placebos. The...

JanOne Successfully Begins Production of JAN101 cGMP Batch for Phase 2b Peripheral Artery Disease (PAD) Trial and Potential Covid-19 Study Company continues to make progress on its potential treatment for PAD, a disease affecting 200 million people worldwide PR Newswire ...

Gainers: Alpha Pro Tech (APT) +13%. NN (NNBR) +9%. BEST (BEST) +9%. JanOne (JAN) +6%. Montrose Environmental (MEG) +6%.Losers: Grindrod Shipping (GRIN) -13%. Titan International (TWI) -10%. Eagle Bulk Shipping (EGLE) -9%. Triumph Group (TGI) -8%. Kratos Defense & Secur...

JanOne Issues September 2020 Shareholder Letter Updating Investors on Recent Pharma Asset Potential for Peripheral Artery Disease Company pursuing additional application for JAN101 to treat COVID-19 complications Stable formulation and engineering for JAN101 will support Pha...

Point Roberts, WA and Delta, BC - September 18, 2020 (Investorideas.com Newswire) Investorideas.com , a global news source and leading retail investor resource announces its weekly roundup of stocks added to its free global stock directories; biotech, gaming and eSport. The newest biotech com...

JanOne ( JAN -3.7% ) has provided an update  related to its strategic alternative process for its legacy businesses first announced in June 2020. More news on: JanOne Inc., Healthcare stocks news, Merger & acquisition news, Read more ...

LAS VEGAS , Sept. 16, 2020 /PRNewswire/ -- JanOne Inc. (Nasdaq: JAN), a company focused on developing treatments for conditions that cause severe pain and drugs with non-addictive, pain-relieving properties, provided an update today regarding its initiatives to pursue a strategic alt...

LAS VEGAS , Sept. 3, 2020 /PRNewswire/ -- JanOne Inc. (Nasdaq: JAN), a company focused on developing  treatments for conditions that cause severe pain and drugs with non-addictive, pain-relieving properties, has confirmed stability of its developmental batch run of JAN101.  Work...